
Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Americans generally like wolves − except when we’re reminded of our politics - 2
The Best Internet Mastering Stages for Expertise Improvement - 3
'All's Fair,' Ryan Murphy's new show starring Kim Kardashian, hit with scathing reviews: 'A girlboss fever dream' - 4
What exactly is the Upside Down in 'Stranger Things'? The wormhole revelation, explained. - 5
Vote In favor of Your Favored Web-based Book Retailor
Full Supreme Court to hear challenge to Judicial Selection Committee law
Oil Tanker Carrying Iraqi Cargo Seen Transiting Strait of Hormuz
Fisherman Attacked by Great White Shark Says ‘My Left Foot Was in His Mouth’
Finding Ideal Date Spots for Two or three Encounters
Navy-Marine Corps Relief Society provides emergency grants to families displaced by Iran war
First SpaceX booster for upgraded Starship fails during test in Texas
NASA chief Jared Isaacman says Texas may get a moonship, not space shuttle Discovery
5 Cell phones of the Year
She was the ultimate '90s fitness influencer. Now she's delivering Uber Eats — and rebuilding her life.










